VINC Projected Dividend Yield
Vincerx Pharma Inc ( NASDAQ : VINC )Vincerx Pharma is a clinical-stage biopharmaceutical company focused on utilizing its development and oncology capabilities to develop therapies intended to address unmet medical needs for the treatment of cancer. Co.'s pipeline consists of enitociclib and a proprietary modular bioconjugation platform, which includes a small molecule drug-conjugate, VIP236 and preclinical antibody drug-conjugates, VIP943 and VIP924. Co. had been granted an exclusive, royalty-bearing, worldwide license under certain Bayer AG patents and know-how to develop, use, manufacture, commercialize, sublicense, and distribute multiple clinical and preclinical stage compounds. 20 YEAR PERFORMANCE RESULTS |
VINC Dividend History Detail VINC Dividend News VINC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |